FROM THE NEWS FEED
The Drug Enforcement Administration published the application on 24 September 2026. Comments are open for 60 days, ending on 23 November 2026, but no specific controlled substances are identified in the provided material.
Continue to the original publication for the complete article.
KEEP EXPLORING
Helus Pharma reported continued development of HLP003 for adjunctive treatment of major depressive disorder and HLP00...
The in vitro studies indicated favourable intestinal absorption, systemic exposure, metabolic stability across specie...
Elevated Healing Center in Manitou Springs provides screening, preparation, a guided psilocybin session and follow-up...
Psychedelics are no magic wand or silver bullet. However, in partnership with talk therapy, physical therapy, and oth...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
There are many factors that can affect your journey, from set and setting to substance and dosage. At Psychedelic Pas...
Personal growth is a lifelong process. We've heard from so many people that, after years of other avenues, a psychede...
Again and again, we find that psychedelics can be the missing element that help people to heal and recover from past ...